This Study Will Assess the Response, Efficacy Compliance, and Inset of Action of Heart Rate Reduction of Bisoprolol (Nerkardou) (Between Low Dose and High Dose) 5 and 10 mg Oral Dissolvable Film (ODF) Treatment In Egyptian Patients With Essential Hypertension.
Condition: Essential Hypertension Intervention: Drug: Nerkardou 5 mg & Nerkardou 10 mg Sponsors: Genuine Research Center, Egypt; Nerhadou International for pharmaceutical& Nutraceutical, Egypt Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials